|
Name: Eluxadoline
Type: Antidiarrheal
AKA: VIBERZI
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
|
IV. History
Eluxadoline, a selective opioid receptor modulator, was developed in the 21st century. It is used for treating irritable bowel syndrome with diarrhea (IBS-D). It represents a novel approach to managing gastrointestinal disorders and is noted for its efficacy in reducing IBS symptoms.
|
|
V. Legal Information
Eluxadoline is a medication used to treat irritable bowel syndrome. It is controlled to manage its medical use and prevent misuse. [Source: UNODC].
US Federal Schedule - IV
Schedule IV drugs, substances, or chemicals are defined as drugs with a low potential for abuse and low risk of dependence. Some examples of Schedule IV drugs are: Xanax, Soma, Darvon, Darvocet, Valium, Ativan, Talwin, Ambien, Tramadol.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
Eluxadoline is used for treating irritable bowel syndrome with diarrhea. It causes reduced gastrointestinal motility and may lead to nausea. Short-term use alleviates symptoms of IBS, while long-term use is generally safe with minimal side effects. Overdose risks include gastrointestinal distress. Safe use involves adherence to prescribed doses. Recent research highlights its efficacy for IBS and potential side effects.  |
|
VII. Psychological Effects
Eluxadoline, a selective opioid receptor modulator, affects mu-opioid and kappa-opioid receptors, leading to pain relief and mood enhancement. Immediate effects include mood elevation and gastrointestinal relief. Long-term use may result in cognitive impairments and mood disturbances. Research focuses on its selective receptor activity and associated risks of psychological dependence.
 |
|
VIII. Culture
Eluxadoline is a medication used to treat irritable bowel syndrome with diarrhea (IBS-D). Its cultural significance is tied to its role in managing gastrointestinal conditions and improving quality of life for patients with IBS-D. Media coverage often highlights its effectiveness and the importance of targeted treatments for gastrointestinal disorders. Eluxadoline is used medicinally and is part of broader discussions about digestive health and the management of chronic gastrointestinal conditions.
 |